Kentucky Communities and Researchers Engaging to Halt the Opioid Epidemic (CARE2HOPE)

NACompletedINTERVENTIONAL
Enrollment

234

Participants

Timeline

Start Date

November 15, 2019

Primary Completion Date

October 27, 2022

Study Completion Date

October 27, 2022

Conditions
Substance UseHIV InfectionsHCV InfectionSexually Transmitted Infections (Not HIV or Hepatitis)Overdose, DrugOpioid Use
Interventions
BEHAVIORAL

Health Linkage

Research staff will: 1) help participants set goals and reduce their health risks by helping them to reflect on personal drug use, sexual relationships, and their consequences in the context of personal values and goals; 2) help link participants to services that they need and want; 3) offer participants the option of HIV and hepatitis C testing, provide the test result, and provide post-test counseling; and 4) provided participants nasal spray naloxone (Narcan) to carry with them in case they encounter someone who has an opioid overdose or in case they have an opioid overdose and a friend can use the naloxone to respond.

BEHAVIORAL

Overdose Education

Participants will complete a 10-minute overdose education training video on preventing, recognizing, and responding effectively to an opioid OD.

Trial Locations (1)

40506

University of Kentucky, Lexington

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

Appalachian Regional Commission

OTHER

collaborator

Substance Abuse and Mental Health Services Administration (SAMHSA)

FED

collaborator

Centers for Disease Control and Prevention

FED

collaborator

Emory University

OTHER

lead

April M Young

OTHER

NCT04134767 - Kentucky Communities and Researchers Engaging to Halt the Opioid Epidemic (CARE2HOPE) | Biotech Hunter | Biotech Hunter